Beta Bionics, Inc. (BBNX)
16.92
+1.22
(+7.80%)
USD |
NASDAQ |
Nov 09, 16:00
16.92
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Total Liabilities (Quarterly) : 42.38M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 42.38M |
| June 30, 2026 | 36.02M |
| March 31, 2026 | 33.17M |
| December 31, 2025 | 41.13M |
| September 30, 2025 | 35.29M |
| June 30, 2025 | 28.34M |
| Date | Value |
|---|---|
| March 31, 2025 | 24.27M |
| December 31, 2024 | 73.63M |
| September 30, 2024 | 64.07M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 51.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | 144.85M |
| Edwards Lifesciences Corp. | 3.183B |
| Intuitive Surgical, Inc. | 3.231B |
| Stryker Corp. | 23.79B |
| Zimmer Biomet Holdings, Inc. | 10.81B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 443.76M |
| Shareholders Equity (Quarterly) | 401.38M |
| Debt to Equity Ratio | 0.0152 |
| Current Ratio | 8.922 |
| Net Debt Paydown Yield | 0.01% |